spacer
home > pmps > winter 2010 > packaging rises to the challenge
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Packaging Rises to the Challenge

We tend to think of the pharmaceutical market as being pretty much recession proof. Just as people have to eat, making the food sector reasonably resilient even in troubled times, so people continue to get sick, whatever the state of the economy. Indeed, there are many reports that link a recession to all sorts of illnesses, notably depression, anxiety, cardiac disease and other maladies.

And of course, the current economic troubles have coincided with the outbreak of the swine flu pandemic. This has not just created high demand for drugs such as Tamiflu, but has also seen a general focus on health and hygiene, with, for example, a huge increase in sales of hand sanitisers and similar products.

Nevertheless, the pharmaceutical sector remains under the same sort of cost pressures as any other market. Indeed, one could argue that pharmaceutical companies have extra pressures to contend with, particularly in terms of the lengthy development process and equally long and stringent regulatory approval that any new drug has to undergo. While the rewards for finding the next breakthrough drug can be enormous, for every drug that succeeds, there are many more that do not make it. The new product development process can be long and expensive, with no guarantee of success at the end. This makes the need to maximise throughput and efficiencies once a drug is in production of paramount importance.

The days when a manufacturing plant could run a patented drug at no more than 50 to 60 per cent capacity, since the value of the product meant costs were not a critical factor, are generally a distant memory. Even where there is high demand for products, competition is fierce and the emphasis for every company is on maximising returns while minimising costs.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Ian Crawford has worked for Reed Exhibitions for the past five and half years, and looks after a portfolio of 10 shows in the industrial and aerospace sectors. His career began with a fiveyear mechanical and production engineering apprenticeship with the MOD, followed by six years with the metrology department of Carl Zeiss Jena, dealing with capital sales for non-contact measuring systems. He then spent 15 years in capital sales with two major German machine suppliers within the injection moulding sector. This extensive experience, including as a regular exhibitor at Reed’s Interplas exhibition, was a major factor in his appointment at Reed, bringing an exhibitor’s insight into the business. Email: ian.crawford@reedexpo.co.uk
spacer
Ian Crawford
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Vaisala Introduces CAB100 Industrial Cabinet for Cleanrooms

Vaisala, a global leader in weather, environmental, and industrial measurements, launches its newest offering for centralized environmental monitoring in cleanrooms: The CAB100 integrates Vaisala’s world-class instruments for monitoring parameters into a simple, pre-configured enclosure.
More info >>

White Papers

Advantages of Quantitative NMR for the Determination of Relative Response Factors

Novatia, LLC

Quantitative NMR (qNMR) is a technique that is being applied broadly and at an increasing rate in the field of pharmaceutical analysis (1). This white paper highlights the advantages of using qNMR to determine Relative Response Factors (RRFs) for pharmaceutical impurities detectable by HPLC. A single determination of RRFs using qNMR allows for simple and accurate quantitation of impurities which eliminates the need for preparation, qualification, and storage of reference standards. An example is presented here, which demonstrates quantitation of known impurities that have variable responses to UV-VIS detection, thereby providing a more accurate assessment of impurity levels than UV-VIS response alone.
More info >>

 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement